BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shen SG, Zhang D, Hu HT, Li JH, Wang Z, Ma QY. Effects of α-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitro. World J Gastroenterol 2008; 14(15): 2358-2363 [PMID: 18416462 DOI: 10.3748/wjg.14.2358]
URL: https://www.wjgnet.com/1007-9327/full/v14/i15/2358.htm
Number Citing Articles
1
Hong-bo Huan, Xu-dong Wen, Xue-jiao Chen, Lin Wu, Li-li Wu, Liang Zhang, Da-peng Yang, Xia Zhang, Ping Bie, Cheng Qian, Feng Xia. Sympathetic nervous system promotes hepatocarcinogenesis by modulating inflammation through activation of alpha1-adrenergic receptors of Kupffer cells. Brain, Behavior, and Immunity 2017; 59 doi: 10.1016/j.bbi.2016.08.016
2
Yani Zhao, Yan Zhang, Yao Li, Min Yang, Jiani Yuan, Yu Cao, Lu Xu, Xuexinyu Ma, Sisong Lin, Junming An, Siwang Wang. Yohimbine hydrochloride inhibits benign prostatic hyperplasia by downregulating steroid 5α-reductase type 2. European Journal of Pharmacology 2021; 908 doi: 10.1016/j.ejphar.2021.174334
3
Teni Ernawati, Fera Kurniadewi, Elvernita June, Mahardhika Kurniaputra, Minarti Minarti, Francis Xavier. Phytochemical Profiling and Biological Activities of Mitragyna speciosa Leaf Extracts: Antioxidant and α-Glucosidase Inhibitory Activities. GAZI UNIVERSITY JOURNAL OF SCIENCE 2026; (Advanced Online Publication) doi: 10.35378/gujs.1911521
4
Heng-tong Hu, Qing-yong Ma, Dong Zhang, Su-gang Shen, Liang Han, Ya-dong Ma, Ruo-fei Li, Ke-ping Xie. HIF-1α links β-adrenoceptor agonists and pancreatic cancer cells under normoxic condition. Acta Pharmacologica Sinica 2010; 31(1) doi: 10.1038/aps.2009.181
5
Jouhyun Jeon, Satra Nim, Joan Teyra, Alessandro Datti, Jeffrey L Wrana, Sachdev S Sidhu, Jason Moffat, Philip M Kim. A systematic approach to identify novel cancer drug targets using machine learning, inhibitor design and high-throughput screening. Genome Medicine 2014; 6(7) doi: 10.1186/s13073-014-0057-7
6
Marisa Coelho, Cátia Soares-Silva, Daniela Brandão, Franca Marino, Marco Cosentino, Laura Ribeiro. β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives. Journal of Cancer Research and Clinical Oncology 2017; 143(2) doi: 10.1007/s00432-016-2278-1
7
Weina Wang, Xin Guo, Huiwen Dan. <p>α2A-Adrenergic Receptor Inhibits the Progression of Cervical Cancer Through Blocking PI3K/AKT/mTOR Pathway</p>. OncoTargets and Therapy 2020;  doi: 10.2147/OTT.S264409
8
Han Yang, Michal Poznik, Shaojian Tang, Peng Xue, Lidong Du, Chenlu Liu, Xiaochuan Chen, Jason J. Chruma. Synthesis of Conformationally Liberated Yohimbine Analogues and Evaluation of Cytotoxic Activity. ACS Omega 2021; 6(29) doi: 10.1021/acsomega.1c02784
9
Mallory Batty, Rachel Pugh, Ilampirai Rathinam, Joshua Simmonds, Edwin Walker, Amanda Forbes, Shailendra Anoopkumar-Dukie, Catherine McDermott, Briohny Spencer, David Christie, Russ Chess-Williams. The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other Cancers. International Journal of Molecular Sciences 2016; 17(8) doi: 10.3390/ijms17081339
10
Rajagopal Anitha, Rajakannu Subashini, Gomathi Kannayiram, Dasararaju Gayathri. Chronic Inflammatory-Modulating Potential of Cassia auriculata with Proinflammatory Cytokine IL-1beta and Its Anticancer Effect on Lung Cancer Cell Line. Anti-Cancer Agents in Medicinal Chemistry 2021; 21(3) doi: 10.2174/1871520620666200811111114
11
Azar Ramezanpour, Kazem Karami, Mahshid Kharaziha, Mostafa Zakariazadeh, Janusz Lipkowski, Azar Shahpiri, Negar Azizi, Mansoor Namazian. A mononuclear PdII complex with Naphcon; crystal structure, experimental and computational studies of the interaction with DNA/BSA and evaluation of anticancer activity. Polyhedron 2021; 206 doi: 10.1016/j.poly.2021.115333
12
Jing Dong, Ji Che, Yuanyuan Wu, Yixu Deng, Xuliang Jiang, Zhiyong He, Jun Zhang. Dexmedetomidine promotes colorectal cancer progression via Piwil2 signaling. Cellular Oncology 2024; 47(4) doi: 10.1007/s13402-024-00944-8
13
Ada María Herrera-García, María Jesús Domínguez-Luis, María Arce-Franco, Estefanía Armas-González, Diego Álvarez de La Rosa, José David Machado, Martina K Pec, Manuel Feria, Olga Barreiro, Francisco Sánchez-Madrid, Federico Díaz-González. Prevention of Neutrophil Extravasation by α2-Adrenoceptor–Mediated Endothelial Stabilization. The Journal of Immunology 2014; 193(6) doi: 10.4049/jimmunol.1400255
14
Jennifer L. Fisher, Elizabeth J. Wilk, Vishal H. Oza, Sam E. Gary, Timothy C. Howton, Victoria L. Flanary, Amanda D. Clark, Anita B. Hjelmeland, Brittany N. Lasseigne. Signature reversion of three disease‐associated gene signatures prioritizes cancer drug repurposing candidates. FEBS Open Bio 2024; 14(5) doi: 10.1002/2211-5463.13796
15
Yang Liu, Xiaochen Yu, Junling Zhuang. Epinephrine Stimulates Cell Proliferation and Induces Chemoresistance in Myeloma Cells through the β-Adrenoreceptor in vitro. Acta Haematologica 2017; 138(2) doi: 10.1159/000478517
16
Konstantinos N Tzirogiannis, Kalliopi T Kourentzi, Sofia Zyga, Vassiliki Papalimneou, Maria Tsironi, Agni D Grypioti, Ioannis Protopsaltis, Dimitrios Panidis, Georgios I Panoutsopoulos. Effect of 5-HT7receptor blockade on liver regeneration after 60-70% partial hepatectomy. BMC Gastroenterology 2014; 14(1) doi: 10.1186/s12876-014-0201-2
17
Perioperative Effects of Surgery, Anesthesia and Analgesics Associated with Cancer Progression: A Review . Journal of Cancer Research Updates 2018; 7(1) doi: 10.6000/1929-2279.2018.07.01.1
18
Bina Raju, Salah O. Ibrahim. Pathophysiology of oral cancer in experimental animal models: a review with focus on the role of sympathetic nerves. Journal of Oral Pathology & Medicine 2011; 40(1) doi: 10.1111/j.1600-0714.2010.00928.x
19
Mary F. McGuire. Pancreatic Cancer: Insights from Counterterrorism Theories. Decision Analysis 2014; 11(4) doi: 10.1287/deca.2014.0301
20
Michele Pellegrino, Maria Antonietta Occhiuzzi, Maria Marra, Francesca Giordano, Fedora Grande, Stefano Aquaro, Stefania Marsico, Paola Tucci. Molecular insights into Silodosin’s anti-cancer effects: a promising repurposing strategy for breast cancer. Cell Death Discovery 2026; 12(1) doi: 10.1038/s41420-026-02973-8
21
Hannah P. Priyanka, Uday P. Pratap, Rahul S. Nair, Ramasamy Vasantharekha, Srinivasan ThyagaRajan. Estrogen-receptor status determines differential regulation of α1- and α2-adrenoceptor-mediated cell survival, angiogenesis, and intracellular signaling responses in breast cancer cell lines. Medical Oncology 2024; 41(5) doi: 10.1007/s12032-024-02322-8
22
Leejin Lim, Hyeonhwa Kim, Jihye Jeong, Sung Hee Han, Young-Bob Yu, Heesang Song. Yohimbine Inhibits PDGF-Induced Vascular Smooth Muscle Cell Proliferation and Migration via FOXO3a Factor. International Journal of Molecular Sciences 2024; 25(13) doi: 10.3390/ijms25136899
23
M Pérez-Sayáns, JM Somoza-Martín, F Barros-Angueira, P Gayoso-Diz, EM Otero-Rey, JM Gándra-Rey, A García-García. Activity of β2-adrenergic receptor in oral squamous cell carcinoma is mediated by overexpression of the ADRBK2 gene: a pilot study. Biotechnic & Histochemistry 2012; 87(3) doi: 10.3109/10520295.2011.592151
24
Jude A. Oben, Trusha Patel, Angelina Mouralidarane, Ann Maj Samuelsson, Phillippa Matthews, Joaquim Pombo, Maelle Morgan, Chad Mckee, Junpei Soeda, Marco Novelli, Lucilla Poston, Paul Taylor. Maternal obesity programmes offspring development of non-alcoholic fatty pancreas disease. Biochemical and Biophysical Research Communications 2010; 394(1) doi: 10.1016/j.bbrc.2010.02.057
25
Anik Banik, Sheikh Rashel Ahmed, Emran Hossain Sajib, Anamika Deb, Shiuly Sinha, Kazi Faizul Azim. Identification of potential inhibitory analogs of metastasis tumor antigens (MTAs) using bioactive compounds: revealing therapeutic option to prevent malignancy. Molecular Diversity 2022; 26(5) doi: 10.1007/s11030-021-10345-w
26
Hermann A.M. Mucke. Drug Repurposing Patent Applications October: December 2021. ASSAY and Drug Development Technologies 2022; 20(2) doi: 10.1089/adt.2022.002
27
Chenxu Liu, Mengqi Tong, Kouharu Otsuki, Wei Li, Feng Feng, Jie Zhang. Structure, bioactivity, biosynthesis, and synthesis of corynanthe alkaloids. Natural Product Reports 2026; 43(4) doi: 10.1039/D5NP00051C
28
Chih-Wei Chiu, Cheng-Ying Hsieh, Chih-Hao Yang, Jie-Heng Tsai, Shih-Yi Huang, Joen-Rong Sheu. Yohimbine, an α2-Adrenoceptor Antagonist, Suppresses PDGF-BB-Stimulated Vascular Smooth Muscle Cell Proliferation by Downregulating the PLCγ1 Signaling Pathway. International Journal of Molecular Sciences 2022; 23(14) doi: 10.3390/ijms23148049
29
Adel M. Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, Mehboob Hoque, Sajjad Karim, Ibtessam M.R. Hussain, Shams Tabrez, Arpita Roy. Identification of Potential Poly (ADP-Ribose) Polymerase-1 Inhibitors Derived from Rauwolfia serpentina: Possible Implication in Cancer Therapy. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/3787162
30
Henry H. Brak, Noelle R.J. Thielman. Norepinephrine mediates adrenergic receptor transcription and oncogenic gene expression in pancreatic ductal adenocarcinoma. Advances in Biological Regulation 2025; 97 doi: 10.1016/j.jbior.2025.101097
31
Andres Missair, Juan Pablo Cata, Gina Votta-Velis, Mark Johnson, Alain Borgeat, Mohammed Tiouririne, Vijay Gottumukkala, Donal Buggy, Ricardo Vallejo, Esther Benedetti de Marrero, Dan Sessler, Marc A Huntoon, Jose De Andres, Oscar De Leon Casasola. Impact of perioperative pain management on cancer recurrence: an ASRA/ESRA special article. Regional Anesthesia & Pain Medicine 2019; 44(1) doi: 10.1136/rapm-2018-000001
32
Nasimudeen R. Jabir, Chelapram K. Firoz, Torki A. Zughaibi, Mohammed Abdullah Alsaadi, Adel M. Abuzenadah, Ahmed Ibrahim Al-Asmari, Ahdab Alsaieedi, Bakrudeen Ali Ahmed, Arun Kumar Ramu, Shams Tabrez. A literature perspective on the pharmacological applications of yohimbine. Annals of Medicine 2022; 54(1) doi: 10.1080/07853890.2022.2131330
33
Adel M. Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, Mehboob Hoque, Sajjad Karim, Ibtessam M. R. Hussain, Shams Tabrez, Arpita Roy. Elucidating Antiangiogenic Potential of Rauwolfia serpentina: VEGFR-2 Targeting-Based Molecular Docking Study. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/6224666
34
Nasimudeen R. Jabir, Mohd Shahnawaz Khan, Nouf Omar Alafaleq, Huma Naz, Bakrudeen Ali Ahmed. Anticancer potential of yohimbine in drug-resistant oral cancer KB-ChR-8–5 cells. Molecular Biology Reports 2022; 49(10) doi: 10.1007/s11033-022-07847-7
35
Ting Fu, Xiaofeng Qin, Yining Ma, Xinyue Yuan, Siyun Wu, Xiyun Ye, Yongyan Dang. Yohimbine hydrochloride inhibits skin melanin synthesis by regulating wnt/β-catenin and p38/MAPK signal pathways. Journal of Dermatological Science 2022; 107(1) doi: 10.1016/j.jdermsci.2022.06.005
36
Nasimudeen R. Jabir, Shams Tabrez, Nojood Altwaijry, Mohd Shahnawaz Khan, Arun Kumar Ramu, Bakrudeen Ali Ahmed. Estimating Anticancer Effects of Yohimbine in DMBA‐Induced Oral Carcinogenesis Hamster Model: Utilizing Biochemical and Immunohistochemical Techniques. Cell Biochemistry and Function 2024; 42(7) doi: 10.1002/cbf.4132